Track the Biofrontera Inc. share price and the full management transaction log of the company, a publicly traded company based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Market capitalisation: €21.4m. The latest transaction was disclosed on 29 July 2026 (Levée d'options). Among the most active insiders: Luebbert Hermann. All data is openly available.
11
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Biofrontera Inc. Strong Buy (bullish), based on 2 analysts. Average price target: US$5.88.
Fundamental score
Ranked 24,991 of 28,958 companies
25.6
score / 100
Value
4
Quality
47
FCF yld-59%
Earn yld-46%
EV/EBITDA·
ROE·
Gross mgn74%
Net mgn-25%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Biofrontera Inc. is a biopharmaceutical company focused on developing treatments for skin diseases. It specializes in innovative solutions for the treatment of skin cancer and other dermatological conditions.